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Abstract. Understanding the biochemical structure and function of the methylenetetrahydrofolate reductase gene (MTHFR)
provides new evidence in elucidating the risk of having a child with Down syndrome (DS) in association with two common
MTHFR polymorphisms, C677T and A1298C. The aim of this study was to evaluate the risk for DS according to the presence
of MTHFR C677T and A1298C polymorphisms as well as the stability of the enzyme configuration. This study included
mothers from Croatia with a liveborn DS child (n = 102) or DS pregnancy (n = 9) and mothers with a healthy child (n =
141). MTHFR C677T and A1298C polymorphisms were assessed by PCR-RFLP. Allele/genotype frequencies differences were
determined using χ2 test. Odds ratio and the 95% confidence intervals were calculated to evaluate the effects of different
alleles/genotypes. No statistically significant differences were found between the frequencies of allele/genotype or genotype
combinations of the MTHFR C677T and A1298C polymorphisms in the case and the control groups. Additionally, the observed
frequencies of the stable (677CC/1298AA, 677CC/1298AC, 677CC/1298CC) and unstable (677CT/1298AA, 677CT/1298AC,
677TT/1298AA) enzyme configurations were not significantly different. We found no evidence to support the possibility that
MTHFR polymorphisms and the stability of the enzyme configurations were associated with risk of having a child with DS in
Croatian population.
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1. Introduction
Down syndrome (DS) or trisomy 21 is the most
prevalent autosomal trisomy detected at birth [2]. Ap-
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proximately 95% of DS cases are of maternal origin,
and the prevalence for DS increases with age of the
mother [12]. A number of studies from distinct geo-
graphic regions have evaluated the role of an abnormal
folate pathway as a possible risk for DS. The folate
pathway plays an important function in DNA synthesis
as well as in DNA methylation. Accurate methylation
of genomic DNA, particularly in the centromeric re-
gion of the chromosome, is crucial for stabilization and
proper separation of the chromosomes during cellular
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division [14,17].
S-adenosylmethionine (SAM) is the major methyl
donor for DNA, protein and lipid methylation, and
its synthesis requires the activity of methylenetetrahy-
drofolate reductase (MTHFR), which catalyzes the
conversion of 5,10 methylenetetrahydrofolate to 5-
methyltetrahydrofolate, the major methyl donor for
remethylation of homocysteine to methionine [15].
Polymorphisms in the human MTHFR gene (C677T
and A1298C) have been identified, which result in a
reduction of MTHFR enzymatic activity [21,35].
The association between the MTHFR C677T poly-
morphism and risk for having a child with DS was first
reported ten years ago [20]. Since the initial study,
many researchers have examined one or both MTHFR
polymorphisms as a potential risk factor for DS, but
these studies have yielded contradictory results [1,3–5,
7–11,18,20,24,26,27,29,30,33,36,39]. Interestingly, a
recent study by Ulvik et al. demonstrated that the lev-
els of total homocysteine (tHcy) associated with the
various MTHFR combinations show significant differ-
ences; the levels of tHcy increase as the levels of fo-
late decrease. Lowest serum folat and highest tHcy
was found for the 677TT/1298AA genotype combina-
tions [34]. These findings led Martinez-Frias to specu-
late that understanding the MTHFR gene structure and
the mechanisms by which folate may reduce homocys-
teine levels in humans has provided a rationale for the
conflicting epidemiological observations of the studies
on the MTHFR C677T and A1298C polymorphisms
and the risk of having a child with DS [23].
The aim of the present study was to assess the risk
for DS in association with (i) maternal polymorphisms
of MTHFR (C677T and A1298C) and (ii) stable or un-
stable MTHFR enzyme dimer configurations as defined
by Ulvik et al. [34].
2. Subjects and methods
Mothers with DS children were recruited from the
Downs syndrome associations in the larger cities of
Croatia (Rijeka, Zagreb, Pula, Zadar, Split, Karlovac,
ˇCakovec and Osijek). Blood samples were collected
from a total of 111 women who had either a liveborn
child with DS (n = 102) or a trisomy 21 pregnancy that
was terminated (n = 9). All DS cases were full trisomy
21; cases with translocation or mosaicism were not in-
cluded in the study. The karyotypes of the parents were
confirmed as normal. The control group consisted of
women who screened negative at the second trimester
screening test for DS performed in the Department of
Biology and Medical Genetics, School of Medicine,
University of Rijeka. The control mothers gave birth
to healthy children, and had no previous miscarriages
or abnormal pregnancies; a total of 141 control DNA
samples were collected from this group. The control
and case groups were age-matched and of the same
ethnicity (Caucasian). The mean age of the case and
control groups was 31.3± 6.4 (range 16–43) and 31.4
± 5.0 (range 18–41) years, respectively (P = 0.867).
Maternal age was calculated as the age of the mother
at the time of conception of the DS child for the case
group or the child who was born after maternal serum
screening for the control group.
For the purpose of this study, we marked MTHFR
genotype combinations according to the stability of the
enzyme configurations as follows [34]:
Stable enzyme configurations = 1 for genotypes
677CC/1298AA, 677CC/1298AC, and 677CC/
1298CC.
Unstable enzyme configurations = 2 for genotypes
677CT/1298AA, 677CT/1298AC, and 677TT/
1298AA.
The Ethical Committee of the Medical School, Uni-
versity of Rijeka, approved the study. Written informed
consent was obtained from all participants in the study.
Genomic DNA was extracted from 3 ml of EDTA-
treated blood using the QIAamp DNA blood FlexiGene
DNA Kit (QIAGEN GmbH, Hilden, Germany) ac-
cording to the manufacturer’s instructions. Genotyping
analyses were performed using the PCR- RFLP tech-
nique. Genotyping for the MTHFR C677T and A1298C
polymorphisms was performed using the method pub-
lished by Coppede et al. [10]. Digested PCR fragments
were separated by electrophoresis on a 3% agarose gel
containing ethidium bromide.
Allele frequencies were calculated by gene count-
ing, and deviations from those estimated by the Hardy-
Weinberg equilibrium were examined using the χ2 test.
Group differences in genotype and allele were analyzed
for statistical significance using the χ2 test. Odds ratio
(OR) and the 95% confidence intervals (CI) were cal-
culated to for heterozygous and homozygous mutant
genotypes was compared with the wild type. Results
were considered statistically significant at P < 0.05.
3. Results
We first examined the distributions of the MTHFR
C677T and A1298C genotypes in the case group of
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Table 1
Genotype and allele frequencies of the MTHFR C677T and A1298C polymorphisms in women
with a DS child (cases) and controls
Polymorphism Genotype Cases (%) Controls (%) OR (95%CI) P
N = 111 N = 141
MTHFR C677T CC 49 (44) 66 (47) 1.0 Reference
CT 49 (44) 64 (45) 1.03 (0.61–1.74) 0.908
TT 13 (12) 11 (8) 1.60 (0.65–3.85) 0.303
CT + TT 62 (56) 75 (53) 1.11 (0.67–1.83) 0.674
Allele C 147 (66) 196 (70) 1.0 Reference
T 75 (34) 86 (30) 1.17 (0.80–1.71) 0.457
MTHFR A1298C AA 48 (43) 63 (45) 1.0 Reference
AC 56 (51) 68 (48) 1.08 (0.64–1.81) 0.768
CC 7 (6) 10 (7) 0.91 (0.32–2.59) 0.873
AC+CC 63 (57) 78 (55) 1.06 (0.64–1.75) 0.819
Allele A 152 (68) 194 (69) 1.0 Reference
C 70 (32) 88 (31) 1.01 (0.69–1.48) 0.985
Table 2
Combined genotypes frequencies of the MTHFR C677T and A1298C polymor-
phisms in women with a DS child (cases) and controls
MTHFR MTHFR Cases (%) Controls (%) OR (95%CI) P
C677T A1298C N = 111 N = 141
CC AA 12 (11) 17 (12) 1.0 Reference
CT AA 23 (21) 35 (25) 0.93 (0.37–2.30) 0.938
TT AA 13 (12) 11 (8) 1.67 (0.56–4,98) 0.514
CC AC 30 (27) 39 (27) 1.08 (0.45–2.62) 0.974
CT AC 26 (23) 29 (20) 1.27 (0.51–3.15) 0.775
TT AC 0 0
CC CC 7 (6) 10 (7) 0.99 (0.29–3.34) 0.766
CT CC 0 0
TT CC 0 0
women with a DS child and in the control group (Ta-
ble 1). No significant difference in these distribu-
tions was observed when compared with those pre-
dicted from the Hardy-Weinberg equilibrium for either
cases or controls. We analyzed the frequencies of the
MTHFR C677T and A1298C alleles and genotypes in
both groups, and no statistically significant differences
in allele or genotype distributions were detected. Ta-
ble 2 shows the frequencies of the nine genotype com-
binations derived from the C677T and A1298C poly-
morphisms in the case and control groups. We did not
detect any statistically significant differences between
the frequencies of genotype combinations in the two
groups. We also assessed the frequencies of the enzyme
configurations (stable or unstable) in the two groups,
and no significant differences were found in frequen-
cies between the case and the control group (Table 3).
4. Discussion
Here we present the first study on the genotype and
allele frequencies of the C677T and A1298C MTHFR
polymorphisms in a group of mothers in Croatia who
had DS pregnancies or a live born DS child. Our find-
ings confirm the general profile of genotype and allele
distributions for MTHFR C677T and A1298C poly-
morphisms in the European population [16,22,28,32,
37]. We did not find any association between MTHFR
C677T polymorphism with the risk for having a child
with DS. The results are in agreement with studies per-
formed in Mediterranean countries [4–11,24,33]. An
association of the MTHFR 677T allele with DS has
also been found in North and South America, Asia,
and Egypt [13,18,20,24,27,36]. Much more contra-
dictory reports have been presented for the MTHFR
A1298C polymorphism [3,4,10,13,24,27,30]. When
the combined maternal MTHFR C677T/A1298C geno-
types were considered, we failed to find any signifi-
cant association with the risk for offspring with DS.
The present results are consistent with the findings ob-
tained in Sicily, France, Turkey, and Brazil [3–5,8,29].
As expected, the combined genotypes 677CT/1298CC,
677TT/1298CC, and 677TT/1298AC were not ob-
served in the case group or in the controls. The find-
ings support linkage disequilibrium between the MTH-
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Table 3
Frequencies of MTHFR enzyme dimer configuration according to stability in women with a DS child
(cases) and controls
Configuration Genotype MTHFR Cases (%) Controls (%) OR (95%CI) P
C677T/A1298C N = 111 N = 141
Stable CCAA, CCAC, CCCC 46 (41) 65 (46) 1.20 (0.73–1.99) 0.540
Unstable CTAA, CTAC, TTAA 65 (59) 76 (54)
FR C677T and A1298C polymorphisms [1,4,10,13,31,
35]. Some authors have discussed the possibility that
these genotype combinations decrease embryonic vi-
ability because they were found in fetuses but rarely
(677TT/1298CC) or not at all in live births [6,19,23].
Our second aim was to evaluate the possibility of the
stability of the enzyme configuration as an indicator
for risk of having a child with DS. To the best of our
knowledge, this is the first report of that kind. Ulvik et
al demonstrated that six distinct enzyme dimer config-
urations are generated from the three common MTHFR
alleles (C-A, C-C, and T-A) [34]. Thus, depending on
the C677T/A1298C MTHFR genotype, one or three of
these configurations is present for any given individu-
al. Some of these enzyme configurations are unstable,
and significant differences were detected in tHcy lev-
els. The 677TT/1298AA genotype is associated with a
strong increase of tHcy and decrease of folate in serum.
Theoretically, 100% of the MTHFR enzyme dimers in
677TT/1298AA subjects are in the unstable configura-
tion, and these patients will be at particular risk when
their folate status is low, as the mutant enzyme requires
much higher levels of folate for stabilizing enzyme ac-
tivity [34,38]. Although not to the extent observed with
the 677TT/1298AA genotype, the 677CT/1298AA and
677CT/1298AC genotypes exhibit enzymes in the un-
stable form as well. Other MTHFR genotype combi-
nations, such as 677CC/1298AA, 677CC/1298AC, and
677CC/1298CC, have one or three stable enzyme dimer
configurations [34]. We postulated that mothers with a
DS child have more likely the MTHFR genotype com-
binations, which lead to producing MTHFR enzyme
with more or less amount of unstable enzyme dimer
configurations than mothers who have healthy child.
The findings from this study, however, did not show any
statistically significant differences in the frequencies of
unstable form of MTHFR enzyme between cases and
controls. We are aware that the relatively small num-
ber of cases in both groups was a limiting factor for
completely addressing the question posed. However,
some features of the present study should be stressed.
First, we had an age-matched case-control study with
absolute uniformity in ethnicity, and the control moth-
ers had a negative personal and family history. The
variation in allele or genotype frequencies among dif-
ferent populations due to ethnic variability or different
stratification in the case-control study design is always
emphasized [9,25,40].
In conclusion, a follow-up study with a larger group
of patients is required, but this would not be enough
to definitively address the problem. In addition to the
genotype, the information regarding personal folate sta-
tus is important because the postulated risk for DS is ex-
pected if the woman has an unstable form of the MTH-
FR enzyme and low folate status at the same time. To
further resolve the problem, the impact of folate status
on MTHFR enzyme configurations should be investi-
gated, not in mothers who have a DS child, but in her
mother [9,23,25]. Unfortunately, this information is
essentially impossible to obtain. On the other hand, the
effect of the maternal folate status on enzyme configu-
ration could be investigated as a risk factor for trisomy
21 survival.
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